Guanoliquin, K.P.D. la C., Juca, D.C.S., Alcocer, Y.P. and Cuadrado, S.P.A. 2026. Modulation of the gut-brain axis through selective inhibition of the sodium-glucose cotransporter type 1: physiological and therapeutic implications. International Journal of Research in Medical Sciences. 14, 7 (Jun. 2026), 3009–3016. DOI:https://doi.org/10.18203/2320-6012.ijrms20262193.